Sign in
4

Changes in Ownership

Sionna Therapeutics, Inc. Filed Acc 0002061851-25-000003

Chief Legal Officer sold 10,250 shares at $40.52 ($415,330)

  • Chief Legal Officer acquired 10,250 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Fitzpatrick Jennifer · Chief Legal Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-12-05 Exercise or conversion : show line 1 in the form 10b5-1 +10,250 $6.11 $62,628 10,250 D
2025-12-05 Sale : show line 2 in the form 10b5-1 −10,250 $40.52 $415,330 0 D
Open-market sales · 10,250 sh · avg $40.52 · $415,330

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-12-05 Exercise or conversion : show line 3 in the form 10b5-1 Non-Qualified Stock Option (right to buy) −10,250 61,185 D
Loading xslF345X05/edgardoc.xml…